[1] Bladé J,Fernándezez DE Larrea C,Rosin?oi L.Extramedullary disease in multiple myeloma in the era of novel agents[J].Br J Haematol,2015,169(6):763~765.
[2] Egan PA,Elder PT,Deighan WI,et al.Multiple myeloma with central nervous system relapse[J].Haematologica,2020,105(7):1780~1790.
[3] 张岚,陈朴,朱建锋,等.5例多发性骨髓瘤中枢神经系统浸润患者的临床及实验室特征分析[J].国际检验医学杂志,2023,44(6):756~760.
[4] 袁渊,任胜男,马小龙,等.多发性骨髓瘤髓外侵犯的CT、MRI表现[J].医学影像学杂志,2016,26(10):1891~1894.
[5] 中国医师协会血液科医师分会,中华医学会血液学分会.中国多发性骨髓瘤诊治指南(2022年修订)[J].中华内科杂志,2022,61(5):480~487.
[6] 谢琼妮,万程尧,姚奕斌,等.多发性骨髓瘤自体干细胞移植后中枢神经系统复发1例并文献复习[J].广西医科大学学报,2021,38(11):2196~2199.
[7] 李璐,冯中原,郭沛,等.累及中枢神经系统多发性骨髓瘤患者的病例对照研究[J].中华血液学杂志,2022,43(12):1016~1020.
[8] Jun BK,HoB,Yuen T.Intracranial multiple myeloma with intraparenchymal involvement:Case report and literature review[J].J Clin Neurosci,2019,59:335~337.
[9] Bhutani M,Foureau DM,Atrash S,et al.Extramedullary multiple myeloma[J].Leukemia,2020,34(1):1~20.
[10] 覃泽东,夏玉梅,陈莉,等.多发性骨髓瘤合并颅内浆细胞瘤的临床及影像学特点分析[J].医学信息,2021,34(5):111~113.
[11] Mussetti A,Dalto S,Montefusco V.Effective treatment of pomalidomide in central nervous system myelomatosis[J].Leuk Lymphoma,2013,54(4):864~866.
[12] Yamashita T,Takamatsu H,Kawamura K,et al.A nationwide survey on central nervous system multiple myeloma in Japan:analysis of prognostic and treatment factors that impact survival[J].Br J Haematol,2021,195(2):217~229.
[13] Elhassadi E,Murphy M,Hacking D,et al.Durable treatment response of relapsing CNS plasmacytoma using intrathecal chemotherapy,radiotherapy,and Daratumumab[J].Clin Case Rep,2018,6(4):723~728.
[14] 丁建波,王恩敏,许云,等.脑转移瘤的放射外科治疗的新模式:2阶段伽玛刀放射外科治疗策略探索及疗效分析[J].临床神经外科杂志,2023,20(6):671~676.
[15] Abdallah AO,Atrash S,Shahid Z,et al.Patterns of central nervous system involvement in relapsed and refractory multiple myeloma[J].Clin Lymphoma Myeloma Leuk,2014,14(3):211~214.
[16] Nieuwenhuizen L,Biesma DH.Central nervous system myelomatosis:review of the literature[J].Eur J Haematol,2008,80(1):1~9.
[17] Chen CI,Masih-Khan E,Jiang H,et al.Central nervous system involvement with multiple myeloma:long term survival can be achieved with radiation,intrathecal chemotherapy,and immunomodulatory agents[J].Br J Haematol,2013,162(4):483~488. |
